November 28, 2018 — The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a rare autoimmune disorder that affects the connection…Original Article
FDA Approves Firdapse (amifampridine) for Lambert-Eaton Myasthenic Syndrome
